Acetaminophen, Caffeine and Dihydrocodeine Bitartrate
- Product NDC
- 71993-300
- 11-digit product format
- 719930300
- Labeler code
- 71993
- Product ID
- 71993-300_9d4d2838-e33e-6544-e053-2a95a90aaf51
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Acetaminophen, Caffeine and Dihydrocodeine Bitartrate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Atland Pharmaceuticals, LLC
- Application
- ANDA204209
- Marketing category
- ANDA
- Marketing start
- 2020-01-30
- Marketing end
- 0000-00-00
- Substance
- ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE
- Active strength
- 325 mg/1; mg/1; mg/1
- Pharmacologic classes
- Central Nervous System Stimulant [EPC],Methylxanthine [EPC],Xanthines [CS],Central Nervous System Stimulation [PE],Full Opioid Agonists [MoA],Opioid Agonist [EPC]
- DEA schedule
- CIII
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 71993-300 | D | Discontinued by firm | 2026-09-09 | ||
| excluded package | package | 71993-300 | 71993-300-30 | D | Discontinued by firm | 2026-09-09 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Code | Status | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded product | product | D | Discontinued by firm | d630ba8d3edf… | 732f749b63fb… | |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 71993-300-30 | D | Discontinued by firm | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | D | Discontinued by firm | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 71993-300-30 | D | Discontinued by firm | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | D | Discontinued by firm | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 71993-300-30 | D | Discontinued by firm | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | D | Discontinued by firm | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 71993-300-30 | D | Discontinued by firm | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | D | Discontinued by firm | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 71993-300-30 | D | Discontinued by firm | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | D | Discontinued by firm | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 71993-300-30 | D | Discontinued by firm | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | D | Discontinued by firm | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 71993-300-30 | D | Discontinued by firm | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | D | Discontinued by firm | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 71993-300-30 | D | Discontinued by firm | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | D | Discontinued by firm | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 71993-300-30 | D | Discontinued by firm | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded product | product | D | Discontinued by firm | ad56d346431e… | cc804d4bbf1e… | |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 71993-300-30 | D | Discontinued by firm | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded product | product | D | Discontinued by firm | 367a005e9d99… | 383a685ebd0f… | |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 71993-300-30 | D | Discontinued by firm | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded product | product | D | Discontinued by firm | 557ba5c1ecfa… | 9c80585c8c6e… | |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 71993-300-30 | D | Discontinued by firm | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded product | product | I | Inactivated by FDA | 86f5da6cb304… | a595104c45d7… | |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded package | package | 71993-300-30 | I | Inactivated by FDA | 86f5da6cb304… | a595104c45d7… |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded product | product | I | Inactivated by FDA | bd6a592717d7… | 303034d00443… | |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded package | package | 71993-300-30 | I | Inactivated by FDA | bd6a592717d7… | 303034d00443… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A204209-001 | ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE | ACETAMINOPHEN; CAFFEINE; DIHYDROCODEINE BITARTRATE | 325MG;30MG;16MG | TABLET / ORAL | 2016-09-30 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A204209-001 | ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE | 325MG;30MG;16MG | TABLET / ORAL | 2016-09-30 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A204209-001 | ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE | 325MG;30MG;16MG | TABLET / ORAL | 2016-09-30 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A204209-001 | ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE | 325MG;30MG;16MG | TABLET / ORAL | 2016-09-30 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A204209-001 | ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE | 325MG;30MG;16MG | TABLET / ORAL | 2016-09-30 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A204209-001 | ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE | 325MG;30MG;16MG | TABLET / ORAL | 2016-09-30 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A204209-001 | ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE | 325MG;30MG;16MG | TABLET / ORAL | 2016-09-30 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A204209-001 | ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE | 325MG;30MG;16MG | TABLET / ORAL | 2016-09-30 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A204209-001 | ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE | 325MG;30MG;16MG | TABLET / ORAL | 2016-09-30 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A204209-001 | ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE | 325MG;30MG;16MG | TABLET / ORAL | 2016-09-30 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A204209-001 | ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE | 325MG;30MG;16MG | TABLET / ORAL | 2016-09-30 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A204209-001 | ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE | 325MG;30MG;16MG | TABLET / ORAL | 2016-09-30 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A204209-001 | ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE | 325MG;30MG;16MG | TABLET / ORAL | 2016-09-30 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A204209-001 | ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE | 325MG;30MG;16MG | TABLET / ORAL | 2016-09-30 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A204209-001 | ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE | 325MG;30MG;16MG | TABLET / ORAL | 2016-09-30 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A204209-001 | ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE | 325MG;30MG;16MG | TABLET / ORAL | 2016-09-30 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A204209-001 | ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE | 325MG;30MG;16MG | TABLET / ORAL | 2016-09-30 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A204209-001 | ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE | 325MG;30MG;16MG | TABLET / ORAL | 2016-09-30 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A204209-001 | ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE | 325MG;30MG;16MG | TABLET / ORAL | 2016-09-30 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A204209-001 | ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE | 325MG;30MG;16MG | TABLET / ORAL | 2016-09-30 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A204209-001 | ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE | 325MG;30MG;16MG | TABLET / ORAL | 2016-09-30 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A204209-001 | ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE | 325MG;30MG;16MG | TABLET / ORAL | 2016-09-30 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A204209-001 | ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE | 325MG;30MG;16MG | TABLET / ORAL | 2016-09-30 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A204209-001 | ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE | 325MG;30MG;16MG | TABLET / ORAL | 2016-09-30 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A204209-001 | ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE | 325MG;30MG;16MG | TABLET / ORAL | 2016-09-30 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A204209-001 | ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE | 325MG;30MG;16MG | TABLET / ORAL | 2016-09-30 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A204209-001 | ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE | 325MG;30MG;16MG | TABLET / ORAL | 2016-09-30 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A204209-001 | ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE | 325MG;30MG;16MG | TABLET / ORAL | 2016-09-30 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A204209-001 | ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE | 325MG;30MG;16MG | TABLET / ORAL | 2016-09-30 | ea99ee380514… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A204209-001 | ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE | 325MG;30MG;16MG | TABLET / ORAL | 2016-09-30 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A204209-001 | ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE | 325MG;30MG;16MG | TABLET / ORAL | 2016-09-30 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A204209-001 | ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE | 325MG;30MG;16MG | TABLET / ORAL | 2016-09-30 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A204209-001 | ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE | 325MG;30MG;16MG | TABLET / ORAL | 2016-09-30 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A204209-001 | ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE | 325MG;30MG;16MG | TABLET / ORAL | 2016-09-30 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A204209-001 | ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE | 325MG;30MG;16MG | TABLET / ORAL | 2016-09-30 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A204209-001 | ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE | 325MG;30MG;16MG | TABLET / ORAL | 2016-09-30 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A204209-001 | ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE | 325MG;30MG;16MG | TABLET / ORAL | 2016-09-30 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A204209-001 | ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE | 325MG;30MG;16MG | TABLET / ORAL | 2016-09-30 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A204209-001 | ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE | 325MG;30MG;16MG | TABLET / ORAL | 2016-09-30 | 3a93d1ddd44b… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A204209-001 | ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE | 325MG;30MG;16MG | TABLET / ORAL | 2016-09-30 | f41ea6bd6efb… | ||
| 2022-09-29 23:25 UTC | 2022-09 | A204209-001 | ACETAMINOPHEN, CAFFEINE AND DIHYDROCODEINE BITARTRATE | 325MG;30MG;16MG | TABLET / ORAL | 2016-09-30 | e64feba35796… |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 71993-300-30 | 2022-04-28 | C162847 | 48780-1 | d6a99b39-d453-a426-e053-dadaa90af4c2 | Acetaminophen, Caffeine and Dihydrocodeine Bitartrate Tablets 325 mg/ 30 mg/ 16 mg - CIII |
| 71993-300-30 | 2022-01-28 | C162847 | 48780-1 | d6a99b39-d453-a426-e053-dadaa90af4c2 | Acetaminophen, Caffeine and Dihydrocodeine Bitartrate Tablets 325 mg/ 30 mg/ 16 mg - CIII |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 71993-300-30 | EA - Each | 71993-300 | df4bcf82-d8ed-477b-9bc1-4d258c5dbf33 | 1 | 2020-02-13 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 71993-300-30 | 71993030030 | 30 TABLET in 1 BOTTLE, PLASTIC (71993-300-30) | 30 tablet | 2020-01-30 | 0000-00-00 | No | No | Current |